Back to PE Pentwater Capital Management LP
STRO
Showing 0 of 21 quarters
Position history for PEPentwater Capital Management LP's holdings in SUTRO BIOPHARMA INC
No. Pentwater Capital Management exited its STRO (Sutro Biopharma) position in Q1 2024. Its Q4 2023 13F listed 450,000 shares worth $1.9M. Pentwater Capital Management already held STRO in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.